This week’s paper describes a drug that inhibits multiple growth factor pathways and may effectively treat patients with retinopathies.
RETINOPATHY
A better drug for diseases of the retina
An integrin-binding peptide derived from collagen IV prevents ligand-induced activation of multiple tyrosine kinase receptors and strongly suppresses ocular neovascularization and vascular leakage.
